The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...

Groundbreaking twice-a-year HIV drug that could stop transmission approved - It's unclear how many people in the US and ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

Gilead Sciences, Inc., a biopharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) ...

Immuno Cure BioTech ('Immuno Cure'), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to ...

The treatments will cost $14,000 a shot, and with numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, funding for such remarkable new drugs may be in short supply.